The list price for Wegovy remains at $1,349 for a one-month supply. Customers whose insurance covers the obesity drug typically pay a copay of no more than $25 per month, the company said. On Feb ...

FILE PHOTO: Wegovy maker Novo Nordisk said it will cut the price of the weight-loss medication to $199 for one month for new customers. The move comes as the FDA phases out compounded versions of ...

Hims & Hers Health Inc.’s stock booked record losses Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth ...

Novo Nordisk, the maker of Wegovy, announced exclusively on "Good Morning America" Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

Our mission, making change happen, has never been as important as it is today. istock-1064904934.jpg© Getty Images Ozempic and Wegovy have been hailed as wonder drugs when it comes to weight loss ...

In a head-to-head study in the New England Journal of Medicine, people taking Zepbound, Wegovy, Zepbound led to greater weight loss.

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy will have the option to buy now and pay later under a partnership announced Tuesday by ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.

The spokesperson also pointed out that in a previous trial, adults who were obese or overweight and who took Wegovy along with diet and exercise lost an average of 15.2% of their weight (~35 ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...

Prime also did a separate analysis of longer-term use. Only 14% of patients were still taking Wegovy after three years, the data show. That was a drop from 24% on Wegovy at the two-year mark.

Why you should care: People taking Zepbound, Eli Lilly’s obesity drug, lost almost 50% more weight than individuals using Novo Nordisk’s Wegovy. According to a study funded by Eli Lilly, the ...